Ni(PPh 3)2Cl2催化2-氯嘧啶与芳基硼酸的Suzuki-Miyaura偶联反应

本文在Ni(PPh 3)2Cl 2催化下顺利实现了不同取代基2-氯嘧啶与芳基硼酸的Suzuki-Miyaura偶联反应。实验表明,取代基的电子效应和空间位阻效应对2-氯嘧啶的反应活性影响较小。该反应产率良好,官能团耐受性好,为2-芳基嘧啶衍生物的合成提供了一类简单有效的方法。     

嘧啶酮衍生物的微波合成

在微波辅助下,Baylis-Hillman加成物与4-氨基-6-氯嘧啶或2-氨基-噻唑反应,快速合成了两类嘧啶酮衍生物——3-取代-7-氯-4H-嘧啶[1,2-b]哒嗪-4-酮和6-取代-5H-噻唑[3,2-a]嘧啶-5-酮,收率81%～98%,其结构经1H NMR,13C NMR,IR和MS确证。     

4-吡唑基-2-芳氧基嘧啶类化合物的合成及除草活性

以2,4-二氯嘧啶为起始原料, 利用两个氯原子的活性差异, 经4-吡唑基-2-氯嘧啶合成了一系列4-吡唑基-2-芳氧基嘧啶类化合物, 通过¹H NMR和元素分析对所合成的化合物进行了结构表征. 初步生物活性测定结果表明, 所合成的化合物都表现出一定的除草活性. 当嘧啶环2位的氯原子被芳氧基取代后, 化合物的除草活性均有不同程度的提高, 例如5c和4a相比, 100 μg•mL^－1时化合物对油菜的抑制率由15.7%提高到85.4%, 对稗草的抑制率由原来的11.6%提高到84.0%.     

2-甲基-4-羟基-6-苯基嘧啶和2-甲基-4-羟基-5-溴-6-苯基嘧啶的高效液相色谱法分离测定

采用ODS-C18色谱柱和紫外检测器,对2-甲基-4-羟基-6-苯基嘧啶和2-甲基-4-羟基-5-溴-6-苯基嘧啶的含量进行HPLC分离测定.以甲醇水=4555为流动相,紫外检测波长为237 nm,样品线性范围为0.001～0.1 mg/mL.2-甲基-4-羟基-6-苯基嘧啶的RSD为0.5%;2-甲基-4-羟基-5-溴-6-苯基嘧啶的RSD为1.0%.     

新型5,5'-双[对-(4-氨基苯氧基)苯氧基]联嘧啶的合成

2-氯-5-溴嘧啶通过碘代,Ullmann,Williamson和还原反应,合成了新型5,5'-双[对-(4-氨基苯氧基)苯氧基]联嘧啶,其结构经1H NMR,IR和元素分析表征.     

嘧啶的研究:氯和硫醇代嘧啶类的作用,4-甲基-5-乙基-6-氨基-2-氧嘧啶的合成

(1)2-乙硫醇基-4-甲基-5-乙基-6-氯代嘧啶和醇钠在醇溶液中反应,则生成它相应的乙硫醇-嘧啶-醚类。(2)2-乙硫醇-嘧啶类有下列结构:式中 X 为卤素或烷氧基。它很容易和氯互相作用,形成嘧啶一砜。(3)当2-乙磺醯-嘧啶类和醇钠及碱作用时,则嘧啶中的乙磺酰基在所有的情况下都相似于一个易于被烷氧基和羟基所置换的卤原子。然而氨和氯-乙磺酰-嘧啶反应时,则氯原子为氨基取代,而乙磺酰基仍然是不作用的。(4)叙述了两种新的合成4-甲基-5-乙基-6-氨基-2-氧-嘧啶的方法。     

嘧啶的研究:氯对硫醇嘧啶的作用2-酮-4-氨基-5,6-二甲基-1,2-二氢-嘧啶的合成

1.甲醇鈉對於2-乙硫醇基-4,5-二甲基-6-氯代嘧啶在甲醇溶液中生成相應的乙硫醇基嘧啶甲醚。 2.氯對於2-乙硫醇基-4,5-二甲基嘧啶衍生物(I),在水溶液中的作用是特殊的,嘧啶中的不飽和現象不被氯化反應改變而硫醇基團被氧化,形成穩定相應嘧啶碸的衍生物(II),因此製備了2-乙磺醯基-4,5-二甲基-6-甲氧基嘧啶和2-乙磺醯基-4,5-二甲基-6-氯代嘧啶. 3.2-乙硫醇-4,5-二甲基-6-甲氧基嘧啶在甲醇中進行氯化反應,現象甚複雜,並且嘧啶碸的產量很低,2-乙硫醇-4,5-二甲基-6-甲氧基嘧啶在甲醇中被氯氧化,首先形成嘧啶碸,後者並不穩定,再與氯作用形成乙磺醯氯和2-氯代-4,5-二甲基-6-甲氧基嘧啶。 4.嘧啶碸與鹼作用,乙磺醯基被羥基取代,同時在嘧啶環6位上的乙氧基保留,因此2-乙磺醯基-6-甲氧基-4,5-二甲基嘧啶與鹼作用,形成2-酮-5,6-二甲基-4-甲氧基-1,2-二氫嘧啶。 5.酒精-氨的溶液作用在氯代乙磺醯基嘧啶得到氨基-乙磺醯基嘧啶,在氯代乙磺醯基嘧啶中,嘧啶環上2位的乙磺醯基仍保留,而6位土的氯被氨基取代。 6.本文敘述了合成4,5-二甲基-2-氧代-6-氨基嘧啶(或2-酮-4-氨基-5,6-二甲基-1,2-二氫化嘧啶)的新方法。     

2-氨基-4,5-二取代烃嘧啶类衍生物的新合成方法

研究了2-氨基-4,5-二烃基取代嘧啶类衍生物的一个新的简易合成方法,该方法以简单且廉价的4个芳香醛和3个脂肪醛为原料,经过四步反应得到12个2-氨基-4,5-二烃基取代嘧啶类化合物,总收率在40%～70%,经氢核磁共振(1H NMR)、碳核磁共振(13C NMR)和高效液质联用(LC-MS)对其目标产物进行表征.     

(E)-2-[2-(6-氯嘧啶-4-基氧基)苯基]-3-甲氧基丙烯酸甲酯的合成工艺改进

以3-(α-甲氧基)亚甲基苯并呋喃-2-(3H)-酮为原料,经3步反应合成了杀菌剂嘧菌酯的重要中间体——(E)-2-[2-(6-氯嘧啶-4-基氧基)苯基]-3-甲氧基丙烯酸甲酯(4),总收率61%。4的结构经NMR表征。     

嘧啶的研究:氯和硫醇嘧啶类的作用:4-甲基-5-正丙基-6-氨基-2-氧嘧啶的合成

1. 2-乙硫基-4-甲基-5-正丙基-6-氯代嘧啶在甲醇溶液与甲醇钠相互作用,和在乙醇溶液与乙醇钠互相作用,分别得到相应的嘧啶-甲醚及嘧啶-乙醚。2. 氯对2-乙硫基-4-甲基-5-正丙基-6-氯代嘧啶,2-乙硫基-4-甲基-5-正丙基-6-甲氧基嘧啶及2-乙硫基-4-甲基-5-正丙基-6-乙氧基嘧啶起作用,得到相应的嘧啶砜,用氯在水溶液中氧化硫醇嘧啶化合物(Ⅰ),此反应是特殊的,对嘧啶环中的双键没有影响,祇有硫醇基团氧化而得到相应的稳定的嘧啶砜(Ⅱ)。3. 将醇氨与2-乙磺醯基-4-甲基-5-正丙基-6-氯代嘧啶作用时,对于2-位上的磺醯基不起反应,取代于6-位的氯被置换为氨基而得到2-乙磺醯基-4-甲基-5-正丙基-6-氨基嘧啶。4. 硷对2-乙磺醯基-4-甲基-5-正丙基-6-乙氧基嘧啶及2-乙磺醯基-4-甲基-5-正丙基-6-甲氧基嘧啶作用,分别得到2-氧代-4-甲基-5-正丙基-6-乙氧基嘧啶及2-氧代-4-甲基-5一正丙基-6-甲氧基嘧啶,因此,嘧啶砜中在2-位的磺醯基与硷反应时被置换为羟基,而取代于6-位的乙氧基和甲氧基则不起反应。5. 叙述了一种合成2-氧代-4-甲基-5-正丙基-6-氨基嘧啶(或1,2-二氢化-2-酮-4-氨基-5-正丙基-6-甲基嘧啶)的新方法。     

Syntheses of 4‐(5‐oxo‐1,2,4‐triazol‐3‐yl)‐sydnones and 4‐(4‐arylamino‐5‐oxo‐1,2,4‐triazol‐3‐yl)‐sydnones from Sydnone Derivatives and Their Fragments

4‐(5‐oxo‐1,2,4‐triazol‐3‐yl)‐sydnones 11 and 4‐(4‐arylamino‐5‐oxo‐1,2,4‐triazol‐3‐yl)‐sydnones 13 have been obtained from a‐chloroformylarylhydrazine hydrochloride 2 . Moreover, the intermediates, including 3, 4 , 9 and 10 , in this study are synthetically informative and valuable. It is also noteworthy that three reactants, 1, 2 and sydnonecarbaldehydes, were prepared from sydnone derivatives and their fragments. The oxidative cyclizations of sydnonecarbaldehyde semicarbazones 9 and carbazones 10 with two different oxidizing agents (Cu(ClO₄)₂ and Fe(ClO₄)₃) have been extensively examined. The reaction time and the yields of cyclizations were affected by the substituents of semicarbazones 9 and carbazones 10.     

Facile Synthesis of Substituted Ethyl 2‐(Chloromethyl)‐2‐hydroxy‐2H‐1‐benzopyran‐3‐carboxylates

Ethyl 2‐(chloromethyl)‐2‐hydroxy‐2H‐chromene‐3‐carboxylates 2a – 2j have been synthesized by reaction of substituted salicylaldehydes with ethyl 4‐chloro‐3‐oxobutanoate, in the presence of piperidine in CH₂Cl₂ at room temperature, in good yields.     

Polymorphism of 3‐(5‐phenyl‐1,3,4‐oxadiazol‐2‐yl)‐ and 3‐[5‐(pyridin‐4‐yl)‐1,3,4‐oxadiazol‐2‐yl]‐2H‐chromen‐2‐ones

This study of 3‐(5‐phenyl‐1,3,4‐oxadiazol‐2‐yl)‐2H‐chromen‐2‐one, C₁₇H₁₀N₂O₃, 1 , and 3‐[5‐(pyridin‐4‐yl)‐1,3,4‐oxadiazol‐2‐yl]‐2H‐chromen‐2‐one, C₁₆H₉N₃O₃, 2 , was performed on the assumption of the potential anticancer activity of the compounds. Three polymorphic structures for 1 and two polymorphic structures for 2 have been studied thoroughly. The strongest intermolecular interaction is stacking of the `head‐to‐head' type in all the studied crystals. The polymorphic structures of 1 differ with respect to the intermolecular interactions between stacked columns. Two of the polymorphs have a columnar or double columnar type of crystal organization, while the third polymorphic structure can be classified as columnar‐layered. The difference between the two structures of 2 is less pronounced. Both crystals can be considered as having very similar arrangements of neighbouring columns. The formation of polymorphic modifications is caused by a subtle balance of very weak intermolecular interactions and packing differences can be identified only using an analysis based on a study of the pairwise interaction energies.     

Structural Diversity in the Self‐assembly of Cd(II) Complexes Containing 2,6‐Dimethyl‐3,5‐dicyano‐4‐(4‐pyridyl)‐1,4‐dihydropyridine

The syntheses, structures and properties of the complexes [CdBr₂( L )₂·4H₂O]_n [ L = 2,6‐dimethyl‐3,5‐dicyano‐4‐(4‐pyridyl)‐1,4‐dihydropyridine], 1 and [Cd(SCN)₂( L )₂(H₂O)]_n, 2 , are reported. In polymeric complexes 1 — 2 , the L ligands bridge the metal centers through the pyrimidyl and cyano nitrogen atoms forming 1‐D double‐stranded chain and zigzag chain, respectively. The L ligands in complex 1 act as κ1, κ1‐bidentate bridging ligand, whereas the L ligands in complex 2 act as κ1‐monodentae and κ1, κ1‐bidentate bridging ligand. The molecules of these complexes are interlinked through various weak interactions that form the packed structure. All the complexes exhibit emissions which may be tentatively assigned as intraligand (IL) π→π* transitions.     

Synthesis and Cytotoxicity of 6‐Pyrrolidinyl‐2‐(2‐Substituted Phenyl)‐4‐Quinazolinones

In our continuing search for potential anticancer candidates, 2‐(3‐methoxyphenyl)‐6‐pyrrolidinyl‐4‐quinazolinone ( JJC‐1 ) was selected as the lead compound. Starting 5‐pyrrolidinyl‐2‐aminobenzamide was prepared using standard methodology from 5‐chloro‐2‐nitrobenzoic acid by reaction with SOCl₂, NH₃, pyrrolidine, and H₂. The starting benzamide then was reacted with 2‐substituted benzaldehyde or benzoyl chloride in N,N‐dimethylacetamide (DMAC) in the presence of NaHSO₃ at 150 °C. Thermal cyclodehydration/dehydrogenation gave the target 6‐pyrrolidinyl‐2‐(2‐substituted phenyl)‐4‐quinazolinones ( 15–22 ). These target compounds were assayed for their cytotoxicity in vitro against six cancer cell lines, including human monocytic leukemia cells (U937), mouse monocytic leukemia cells (WEHI‐3), human hepatoma cells (HepG2, Hep3B) and human lung carcinoma cells (A549, CH27). Most of them exhibited significant cytotoxic effect toward U937 and WEHI‐3 cells, with EC₅₀ values ranging from 0.30 to 10.10 μM. Compound 19 was investigated further for its action mechanisms. Preliminary findings indicated that compound 19 induced G2/M arrest and apoptosis on U937 cells.     

A Convenient Synthesis of 2,3‐Dihydro‐4H‐thiopyrano[2,3‐b]‐, ‐[2,3‐c]‐, or ‐[3,2‐c]pyridin‐4‐ones by the Reaction of the Corresponding 1‐(Chloropyridinyl)alk‐2‐en‐1‐ones with NaSH

2,3‐Dihydro‐4H‐thiopyrano[2,3‐b]pyridin‐4‐ones 4 were prepared by a three‐step sequence from commercially available 2‐chloropyridine ( 1 ). Thus, successive treatment of 1 with ⁱPr₂NLi (LDA) and α,β‐unsaturated aldehydes gave 1‐(2‐chloropyridin‐3‐yl)alk‐2‐en‐1‐ols 2 , which were oxidized with MnO₂ to 1‐(2‐chloropyridin‐3‐yl)alk‐2‐en‐1‐ones 3 . The reactions of 3 with NaSH?n H₂O proceeded smoothly at 0° in DMF to provide the desired thiopyranopyridinones. Similarly, 2,3‐dihydro‐4H‐thiopyrano[2,3‐c]pyridin‐4‐ones 8 and 2,3‐dihydro‐4H‐thiopyrano[3,2‐c]pyridin‐4‐ones 12 were obtained starting from 3‐chloropyridine ( 5 ) and 4‐chloropyridine ( 9 ), respectively.     

Reaction of Ketene Dithioacetals with Pyrazolylcarbohydrazide： Synthesis and Biological Activities of Ethyl 5-Amino-1-（5＇-methyl-1 ＇-t-butyl-4＇-pyrazolyl）carbonyl-3-methylthio-1 H-pyrazole-4-carboxylate

The title compound, C16H23N5O3S, ethyl 5-amino-1-(5‘-methyl-1‘-t-butyl-4‘-pyrazolyl)carbonyl-3-methylthio-1H-pyrazole-4-carboxylate (5) has been synthesized by the treatment of ethyl 2-cyano-3,3-dimethylthioacrylate with 1-t-butyl-5-methyl-4-hydrazinocarbonylpyrazole (4) in refluxed ethanol. The possible mechanism of the above reaction was also discussed. The results of biological test show that the title compound has fungicidal and plant growth regulation activities.     

Alternative Synthesis of 2‐Hydroxy‐3,5,5‐trimethylcyclopent‐2‐en‐1‐one

The 2‐hydroxy‐3,5,5‐trimethylcyclopent‐2‐en‐1‐one ( 1 ) was synthesized in 42% yield by rearrangement of epoxy ketone 10 on treatment with BF₃⋅Et₂O under anhydrous conditions. Intermediate 10 was available from the known enone 8 , either via direct epoxidation (60% H₂O₂, NaOH, MeOH; yield 50%), or via reduction to the corresponding allylic alcohol 14 (LiAlH₄, THF), followed by epoxidation ([VO(acac)₂], ^tBuOOH) and reoxidation under Swern conditions, in 37% total yield.     

Synthesis of (−)‐3‐Carene‐2,5‐dione via Allylic Oxidation of (+)‐3‐Carene

Activated carbon‐supported CuCl₂ (CuCl₂/AC) is a heterogeneous catalyst for the liquid‐phase selective allylic oxidation of (+)‐3‐carene with tert‐butyl hydroperoxide (TBHP) and O₂ to produce (?)‐3‐carene‐2,5‐dione. The possible reaction mechanism and the effects of different factors on the allylic oxidation were investigated. The optimal conditions are as follows: reaction temperature, 45 °C; molar ratio of CuCl₂ to (+)‐3‐carene, 1%; volume ratio of (+)‐3‐carene to TBHP, 1:3; and reaction time, 12 h. Under the optimal conditions, the conversion of (+)‐3‐carene reached 100%, whereas the selectivity for (?)‐3‐carene‐2,5‐dione reached 78%. The CuCl₂/AC catalyst was characterized via X‐ray diffraction, and the chemical structure of the target compound was identified via infrared spectroscopy, proton nuclear magnetic resonance spectroscopy, mass spectrometry, and optical analysis.     

Synthesis of 3‐Aryl‐2‐methoxyinden‐1‐one (Z)‐Phenylhydrazones via Hydrobromic Acid‐Mediated Cyclization of 2‐(1‐Aryl‐2‐methoxyethenyl)benzaldehyde Phenylhydrazones

2‐(1‐Aryl‐2‐methoxyethenyl)benzaldehydes 2 , obtained by successive treatment of 1‐(1‐aryl‐2‐methoxyethenyl)‐2‐bromobenzenes 1 with BuLi and 1‐formylpiperidine, were transformed to the corresponding phenylhydrazones 3 on treatment with PhNHNH₂. When these hydrazones were allowed to react with conc. HBr, cyclization, followed by dehydrogenation with air occurred, furnished 3‐aryl‐2‐methoxyinden‐1‐one (Z)‐phenylhydrazones 4 .